English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, December 12, 2024
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1, an AI-Driven Personalized Oral Cancer Vaccine, at ESMO Immuno-Oncology Congress 2024
Monday, December 9, 2024
NEC begins sale of 100G QSFP28 ZR4 single-fiber bi-directional optical transceiver
Friday, November 29, 2024
JAL and NEC Test AI-Powered Carry-On Baggage Analysis Solution
Wednesday, November 20, 2024
Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Monday, November 18, 2024
World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
富士通など、世界初 スーパーコンピュータ「富岳」を用いてグラフ解析性能200 TeraTEPSを突破
Friday, December 17, 2021
NEC Establishes New US$150 Million CVC Fund
NEC、物流倉庫における入出荷作業の生産性向上に向け次世代型自動搬送ロボットを活用したソリューションを開発
Thursday, December 16, 2021
NEC Develops Secure Biometric Authentication Technology to Enable Certification with Encrypted Face Information
Wednesday, December 15, 2021
BostonGene and NEC Announce Global Partnership
NEC Corporation Links

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575